Research And Development Tenders

Acquisition of Office Supplies (Year 4)

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Telmisartan Amlodipine, Atc C09db04 for the Period 03/01/2023 - 02/28/2025

Dynamic Procurement System: Medicinal Products and Products Comparable to Them

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Active Ingredient Bempedoic Acid Ezetimibe, Atc C10ba10 for the Period 03/01/2023 - 02/28/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Carglumic Acid, Atc A16aa05 for the Period 03/01/2023 - 02/28/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Pipamperone, Atc N05ad05 for the Period 03/01/2023 - 02/28/2025

1 Type other than Solar Power Generation Device

Oil Plants and 5 other Species

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Elbasvir Grazoprevir, Atc J05ap54 for the Period 03/01/2023 - 02/28/2025

Open House Original Discount Represent 2023-07 - Cobicisistat / Emtricitrabin / Tenofovi a Altoviid Go))